Top insider buys and sells disclosed on Friday

The article is a roundup of insider trading disclosures, led by heavy selling in CoreWeave totaling more than $500 million across multiple filings, alongside several insider buys in System1, MEGI, Primoris, Spruce Power, and GAM. CoreWeave sales were executed mostly around $117.79-$120.86 per share, while System1 CFO Tridivesh Kidambi bought 26,910 shares at $3.00 and Primoris director Terry D. McAllister’s purchase was tied to dividend reinvestment. The content is informational and mildly relevant to individual stock trading sentiment, but it does not include a broader fundamental catalyst or market-wide signal.

Analysis

The signal is split: small-cap insiders are buying weakness, while a large, sophisticated holder is distributing a high-flyer into strength. That combination usually matters more for positioning than fundamentals — it suggests capital is rotating out of crowded winners and into idiosyncratic laggards where insider alignment is still underappreciated. The best read-through is not “insiders are bullish/bearish” in aggregate, but that liquidity is still available for the right stories and scarce for the wrong ones.

CRWV is the cleanest supply overhang. Repeated block sales from a complex affiliated holder after a multimonth re-rating imply persistent secondary supply, and that can cap upside even if the business remains structurally attractive. In names like this, the first-order risk is not a collapse in fundamentals; it’s multiple compression when incremental buyers realize the easy upside has already been monetized by informed holders.

SST and SPRU look like different versions of the same setup: depressed price, insider buying, and a market willing to pay for optionality. SST’s buy is meaningful because it is discretionary capital at a time of severe drawdown, which can matter more than size in microcaps; SPRU’s repeated purchases add credibility to the thesis that the stock’s prior rally is not fully exhausted. PRIM’s token reinvestment is low-signal — the move is mechanical, not a conviction buy — and GAM is more of a yield/ownership-support story than a catalyst.

The contrarian angle is that the market may be over-anchoring on headline performance and underweighting balance-sheet or dilution risk in the losers, while over-discounting insider support in the smaller names. If CRWV can hold above the recent sale band, the selling may prove absorbable; if not, expect a shallow but persistent air pocket over the next few weeks as arbitrage and momentum holders step back.

Key Decisions for Investors

• Short-term: fade CRWV strength via call spreads or a modest short against the tape for 2-4 weeks; the edge is in persistent supply overhang, not a fundamental collapse. Risk: squeeze if post-sale demand absorbs the block and price reclaims the recent distribution zone.
• Buy SST only on confirmation of stabilization, not immediately: scale in over 1-2 sessions if volume contracts and $2.00 holds. This is a high-beta microcap recovery trade with asymmetric upside if insider buying attracts follow-on interest, but liquidity risk is severe.
• Initiate a tactical long SPRU on pullbacks toward the $4.00 area with a tight stop below recent support; repeated insider purchases raise the probability of a continued momentum extension over the next 1-3 months. Take profits into any move back toward the prior peak as the stock has already been bid aggressively.
• Treat PRIM as a hold, not a new buy, if already owned; the disclosed purchase is non-discretionary and the stock remains expensive after a 1-year rerating. New longs should wait for a broader market de-risk or a fundamental reset.
• Use GAM as a yield screen only, not an insider-signal trade; the preferred stock and trust ownership make it better suited for income accounts than catalyst-driven capital appreciation.